大洋生物(003017.SZ):子公司2-氯-6-氟苯甲醛等含氟系列產品項目試生產
格隆匯 12 月 22日丨大洋生物(003017.SZ)公佈,公司所屬全資子公司福建舜躍科技股份有限公司(“福建舜躍”)自有資金建設的“年產1500噸2-氯-6-氟苯甲醛等含氟芳香烴系列”項目已完成工程主體建設及設備安裝、調試工作,近日試生產方案經專家評審通過,符合試生產條件,正式進入試生產階段。
福建舜躍於2017年11月在福建省邵武市金塘工業園區設立,首期投資項目為“年產1500噸2-氯-6-氟苯甲醛等含氟芳香烴系列”,其中:氟苯650t/a、2-氯-6-氟苯甲醛系列400t/a、4-氟苯甲醛系列200t/a、2-氟苯甲醛系列200t/a和4-氯-2-氟苯甲醛系列50t/a,合計1500t/a。
項目的建成投產符合公司的戰略規劃,可以有效解決公司目前存在的含氟系列產品產能瓶頸,有助於進一步豐富公司含氟精細化學品品種。若項目全面投產,將有助於公司在含氟精細化學品穩定發展的基礎上,增加新的利潤增長點,提高公司市場綜合競爭力和盈利能力。該項目投產運營將對公司未來經營業績產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.